Nucana Plc
Clinical trials sponsored by Nucana Plc, explained in plain language.
-
Can a new nucleotide analogue boost cancer treatment?
Disease control TerminatedThis trial is testing an experimental drug called NUC-3373, a nucleotide analogue, in combination with standard cancer drugs for people with advanced solid tumors. The study has two parts: one combining NUC-3373 with pembrolizumab, and the other combining it with docetaxel. The g…
Phase: PHASE1, PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New combo for colorectal cancer shows promise but trial halted early
Disease control TerminatedThis phase 2 trial tested a new drug combination (NUFIRI-bev) against the standard treatment (FOLFIRI-bev) in 171 people with metastatic colorectal cancer that had already been treated. The goal was to see if the new combo could delay cancer growth better than the standard. Howev…
Phase: PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jun 26, 2026 15:54 UTC